British Journal of Anaesthesia. Halothane in status asthmaticus. Mazze RI, et al. Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. Spencer EM, et al. Plasma inorganic fluoride concentrations during and after prolonged greater than 24 h isoflurane sedation: effect on renal function.
Inorganic fluoride and prolonged isoflurane anesthesia in the intensive care unit. Perouansky M, Hemmings HC. Yamakage M, Namiki A. Cellular mechanisms of airway smooth muscle relaxant effects of anesthetic agents.
J Anesth. Yamakage M, et al. Am J Physiol. Pabelick CM, et al. Effect of halothane on intracellular calcium oscillations in porcine tracheal smooth muscle cells. Schimmel C, et al. Soluble gas exchange in the pulmonary airways of sheep. Swenson ER, et al. Conducting airway gas exchange: diffusion-related differences in inert gas elimination. J Appl Physiol ; 72 4 — Kelly L, et al. Bronchial blood flow affects recovery from constriction in dog lung periphery.
Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. Butler J. The bronchial circulation. News in Physiological Sciences. Pierce RJ, et al. Comparison of intravenous and inhaled terbutaline in the treatment of asthma. Werner HA. Status asthmaticus in children: a review. Wiklund CU, et al. Relaxation by sevoflurane, desflurane and halothane in the isolated guinea-pig trachea via inhibition of cholinergic neurotransmission.
Interactions of volatile anesthetics with cholinergic, tachykinin, and leukotriene mechanisms in isolated Guinea pig bronchial smooth muscle. Lindeman KS, et al. Interaction between halothane and the nonadrenergic, noncholinergic inhibitory system in porcine trachealis muscle. Warner DO, et al. Direct and neurally mediated effects of halothane on pulmonary resistance in vivo. Brown RH, et al. Comparison of low concentrations of halothane and isoflurane as bronchodilators.
Mechanism for the reduction in pulmonary resistance induced by halothane. The Journal of pharmacology and experimental therapeutics. Lovich MA, et al. A mass balance model for the Mapleson D anaesthesia breathing system. Sommer LZ, et al. A simple breathing circuit minimizing changes in alveolar ventilation during hyperpnoea. The European respiratory journal. Brogan TV, et al. Carbon dioxide added late in inspiration reduces ventilation-perfusion heterogeneity without causing respiratory acidosis.
Farr SJ, et al. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.
Mourgeon E, et al. Distribution of inhaled nitric oxide during sequential and continuous administration into the inspiratory limb of the ventilator. Suki B, et al. Avalanches and power-law behaviour in lung inflation.
Amini R, Kaczka DW. Impact of ventilation frequency and parenchymal stiffness on flow and pressure distribution in a canine lung model. Ann Biomed Eng. Amin SD, et al. Modeling the dynamics of airway constriction: effects of agonist transport and binding.
Vinegar A. PBPK modeling of canine inhalation exposures to halogenated hydrocarbons. Toxilogical Sciences. A technical and clinical evaluation. Assessment of time-domain analyses for estimation of low-frequency respiratory mechanical properties and impedance spectra. Blanch L, et al. Volumetric capnography in the mechanically ventilated patient. Minerva Anestesiologica. Majumdar A, et al. Relating airway diameter distributions to regular branching asymmetry in the lung. Physical review letters.
It has been suggested that NIV used in this setting may lead to delays in reintubation once respiratory compromise has occurred, which in turn may increase patient morbidity and mortality; 51 as such, its use is not supported in this setting. Following extubation, the conventional method of preventing hypoxia is application of controlled oxygen therapy COT , usually via a facemask with the fraction of inspired oxygen targeted to a physiological parameter.
In addition, mucosal drying may occur secondary to a lack of humidification, 52 increasing the risk of extubation failure secondary to secretion retention. Maggiore et al. Hernandez et al. A more recent study, 56 terminated early due to recruitment issues, found no significant difference in the frequency of post extubation respiratory failure, time to respiratory failure, or length of ICU and hospital stay with HFNOT.
A recently published meta-analysis examining the role of reintubation in post extubation patients suggested that HFNOT is more effective at preventing reintubation than COT 57 and may be as effective as NIV in this setting but without the side effects and patient tolerance problems that may hamper effective NIV delivery.
It is important to note that one of the larger studies in the data pool excluded patient groups known to respond well to post extubation NIV, such as those with COPD and cardiogenic pulmonary oedema; thus, the impact of NIV may have been underestimated in this trial. The use of HFNOT in post extubation patients is a promising development, particularly in those patients deemed at a low risk of developing extubation failure or where NIV intolerance may be an issue.
The precise role of HFNOT and how it may be used alongside NIV to achieve optimal clinical outcomes requires further clarification, and robust trials are needed in this important area.
Despite many recent advances in ICU practice, optimal management of extubation remains a significant challenge to healthcare providers and carries a significant weight of morbidity and mortality should extubation failure occur. Several weaning strategies are well described in the literature, with an organised approach and consistency in practice seemingly more important than the weaning method used. Although a number of factors are described that may predict extubation failure, few of these are easily modifiable and no universal consensus exists to guide clinicians on when exactly to extubate.
A number of interventions are available to support patients who have been recently extubated, and in particular the timely application of NIV may be greatly beneficial, especially in patients with chronic lung disease or when risk factors present for extubation failure.
There is also growing interest in the use of HFNOT in lower-risk patients, and this therapy may play a useful role in carefully selected post extubation populations. It is evident from the literature that careful planning and assessment at every stage of the patient journey through the ICU, from an organised multi-disciplinary team approach to weaning, through to provision of suitable respiratory support following extubation, are essential to achieve the best possible outcomes in this challenging patient group.
Nothing comes close to some fine, french-made dark synth. Emergent Behavior by Glitch Black. Glitch here offers intense, anthemic darksynth very well resembling a cyborg revolt. Pure energy indeed.
Double Line by Dragon Inn 3. Possessor by GosT. Bandcamp Album of the Day Mar 23, Explore music. XARGON From the moment you press play prepare to be blasted into a cybernetic frenzy, this is some masterful cyberpunk.
Make sure to pair with Side B! Christian P. Gerhard H. Henry L. Author information Copyright and License information Disclaimer. These updated Guidelines contain new evidence from recent Cochrane reviews and the medical literature since The prenatal care section has been updated by Prof. Gerard H. There are also new recommendations covering less invasive surfactant administration.
Karger AG, Basel. This article has been cited by other articles in PMC. Abstract As management of respiratory distress syndrome RDS advances, clinicians must continually revise their current practice. Key Words: Antenatal steroids, Continuous positive airway pressure, Evidence-based practice, Hyaline membrane disease, Mechanical ventilation, Nutrition, Oxygen supplementation, Patent ductus arteriosus, Preterm infant, Respiratory distress syndrome, Surfactant therapy, Thermoregulation.
Introduction Respiratory distress syndrome RDS remains a significant problem for preterm babies, although management has evolved gradually over the years resulting in improved survival for the smallest infants but with unacceptable rates of bronchopulmonary dysplasia BPD at least in part due to reduced use of postnatal steroids [ 1 ].
Table 1 Representations of quality of evidence and strength of recommendations. Open in a separate window. Prenatal Care Lack of antenatal care increases risk of death or severe morbidity [ 9 ]. Delivery Room Stabilisation European Resuscitation Guidelines should be used to deal with asphyxiated babies with hypoxia who need urgent airway opening manoeuvres and lung inflation to restore cardiac output [ 33 ].
Recommendations 1 Delay clamping the umbilical cord for at least 60 s to promote placento-fetal transfusion A1. Surfactant Therapy Surfactant therapy plays an essential role in management of RDS as it reduces pneumothorax and improves survival.
Surfactant Administration Methods Surfactant administration requires an experienced practitioner with intubation skills and ability to provide MV if required. When to Treat with Surfactant? Table 2 Surfactant preparations animal-derived licensed in Europe in Oxygen Supplementation beyond Stabilisation In the last 3 years, little has changed in terms of refining previous recommendations for oxygen saturation targeting based on data from the NeOProm collaboration [ 83 ]. Non-Invasive Respiratory Support Recently, it has been emphasised that preterm infants should be managed without MV where possible and if ventilation is needed to minimise the time an endotracheal tube is used.
MV Strategies Despite best intentions to maximise non-invasive support, many small infants will initially require MV, and about half of those less than 28 weeks' gestation will fail their first attempt at extubation with these having higher mortality and morbidity [ ].
Permissive Hypercarbia Targeting arterial CO 2 levels in the moderately hypercarbic range is an accepted strategy to reduce time on MV [ ]. Caffeine Therapy Optimising success of non-invasive support involves use of caffeine therapy as a respiratory stimulant. Postnatal Steroids Despite best efforts to optimise use of non-invasive support, some infants will remain on MV with the risk of lung inflammation and increased risk of BPD. Monitoring and Supportive Care To achieve best outcomes for preterm babies with RDS, optimal supportive care with monitoring physiological variables is important.
Temperature Control Maintaining body temperature between Antibiotics Antibiotics are often started in babies with RDS until sepsis has been ruled out but policies should be in place to narrow the spectrum and minimise unnecessary exposure.
Early Fluids and Nutritional Support The smallest infants have very high initial transcutaneous losses of water, and water and sodium move from the interstitial to the intravascular compartments making fluid balance challenging. Recommendations 1 Core temperature should be maintained between Managing Blood Pressure and Perfusion Antenatal steroids, delayed cord clamping and avoidance of MV are associated with higher mean blood pressure after birth.
Recommendations 1 Treatment of hypotension is recommended when it is confirmed by evidence of poor tissue perfusion such as oliguria, acidosis and poor capillary return rather than purely on numerical values C2. Miscellaneous Since the Guidelines, we have included a brief section on aspects of RDS management that arise infrequently.
Tocolytics can be used to allow time for steroids to take effect or for safe transfer where appropriate. Pulse oximetry can help guide heart rate response to stabilisation.
A treatment threshold of FiO2 0. Repeat doses of surfactant may be required if there is ongoing evidence of RDS. Babies should be maintained on non-invasive respiratory support in preference to MV if possible. After 1—2 weeks, systemic steroids should be considered to facilitate extubation if the baby remains ventilated. Haemoglobin should be maintained at acceptable levels. References 1.
European Association of Perinatal Medicine European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med. European Association of Perinatal Medicine European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - update. European Association of Perinatal Medicine European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants— update.
European consensus guidelines on the management of respiratory distress syndrome - update. European Association of Perinatal Medicine. Zhonghua Er Ke Za Zhi.
Neonatal outcomes in extremely preterm newborns admitted to intensive care after no active antenatal management: a population-based cohort study.
J Pediatr. Interventions for women with mid-trimester short cervix: which ones work? Ultrasound Obstet Gynecol. Vaginal progesterone, oral progesterone, OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis. Am J Obstet Gynecol. Cervical stitch cerclage for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev. Son M, Miller ES. Predicting preterm birth: cervical length and fetal fibronectin.
Semin Perinatol. Perinatal outcomes for extremely preterm babies in relation to place of birth in England: the EPICure 2 study. Antibiotics for preterm rupture of membranes. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. Tocolysis for women in preterm labour Green—top Guideline No.
Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Association of antenatal steroid exposure with survival among infants receiving postnatal life support at 22 to 25 weeks' gestation. N Engl J Med. Antenatal corticosteroids beyond 34 weeks gestation: what do we do now?
Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. JAMA Pediatr.
Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Association of fetal growth restriction with neurocognitive function after repeated antenatal betamethasone treatment vs placebo: secondary analysis of the ACTORDS randomized clinical trial.
Resuscitation and support of transition of babies at birth. Crying and breathing by extremely preterm infants immediately after birth. Saugstad OD. Delivery room management of term and preterm newly born infants. Ventilation onset prior to umbilical cord clamping physiological-based cord clamping improves systemic and cerebral oxygenation in preterm lambs.
PLoS One. Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis. Cord Pilot Trial Collaborative Group Randomised trial of cord clamping and initial stabilisation at very preterm birth. Effect of umbilical cord milking on morbidity and survival in extremely low gestational age neonates.
Benefits of umbilical cord milking versus delayed cord clamping on neonatal outcomes in preterm infants: A systematic review and meta-analysis. A randomized clinical trial of umbilical cord milking vs delayed cord clamping in preterm infants: neurodevelopmental outcomes at months of corrected age.
Haemodynamic effects of umbilical cord milking in premature sheep during the neonatal transition. Repetitive versus standard tactile stimulation of preterm infants at birth - A randomized controlled trial. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. Oronasopharyngeal suction versus wiping of the mouth and nose at birth: a randomised equivalency trial. Sustained inflations and avoiding mechanical ventilation to prevent death or bronchopulmonary dysplasia: a meta-analysis.
Eur Respir Rev. Presented at the Pediatric Academic Societies meeting. Toronto: Abstract A randomized trial of nasal prong or face mask for respiratory support for preterm newborns.
Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev. Use of heated humidified gases for early stabilization of preterm infants: a meta-analysis. Front Pediatr. BradyPrem study: heart rate is the most vital signs during resuscitation of preterms. Heart rate assessment immediately after birth. Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth.
Acta Paediatr. Outcomes of oxygen saturation targeting during delivery room stabilisation of preterm infants. Oxygen therapy of the newborn from molecular understanding to clinical practice. Pediatr Res. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Early surfactant administration with brief ventilation vs. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Sedation during minimal invasive surfactant therapy: a randomised controlled trial. CureNeb Study Team: Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial.
Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Lung ultrasound score predicts surfactant need in extremely preterm neonates. Escourrou G, De Luca D.
Lung ultrasound decreased radiation exposure in preterm infants in a neonatal intensive care unit. Rapid test for lung maturity, based on spectroscopy of gastric aspirate, predicted respiratory distress syndrome with high sensitivity.
Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. BMC Pediatr. Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis.
The frequency of filter inspection and the parameters of this inspection are established by each facility to meet their unique needs. Effects of volume guaranteed ventilation combined with two different modes in preterm infants. The process of successfully weaning patients from invasive mechanical ventilation is a great challenge for all Long Tall Sally - Elvis Presley - Elvis Presley providers working in critical care. Recently, it has been emphasised that preterm infants should be managed without MV where possible Refuge - Our Lady Peace - Burn Burn Burn if ventilation is needed to minimise the time an endotracheal tube is used. This supports the conclusion that if incinerator emissions result in violation of air-quality standards, the adverse health effects attributable to the excesses can be expected. PLoS Pathog. PAP is a non-invasive and non-pharmacological Black And White - The Spinners - Not Quite Folk for HF in the acute setting and is now globally used. Article Google Respiratory Circuit - Wolftron - 161 (Side A) 2 Peiris, J. Ksiazek, T.
Gotta Get Back - Shelby Lynne - I Am Shelby Lynne, Allegro Molto E Con Brio - Beethoven*, Friedrich Gulda - Piano Sonatas (Complete), Theme For Great Cities - Simple Minds - Sister Feelings Call, Over The Bridge - Bruce Broughton - Homeward Bound II: Lost In San Francisco (Original Motion Pictur, Psycho-Pressure - Various - Untitled